Suggestions
Greg Leibfreid
Senior Manager at Janssen Pharmaceutical Companies of Johnson and Johnson
Professional Background
Greg Leibfreid is a distinguished professional in the pharmaceutical and healthcare sectors, currently serving as the Director of Medical Informatics at Janssen, Pharmaceutical Companies of Johnson and Johnson. With a career that spans several impactful roles within the industry, Greg brings a wealth of experience and expertise in leveraging medical informatics to enhance patient outcomes and streamline healthcare delivery.
In his current position at Janssen, Greg leads initiatives that focus on integrating cutting-edge technology with clinical operations. His strategic vision and leadership empower teams to harness data analytics and informatics in support of pharmaceutical innovation and healthcare improvement. As the Director of Medical Informatics, Greg is committed to advancing the use of data-driven decision-making in the pharmaceutical industry, ensuring that healthcare providers have the best possible tools and insights to serve their patients effectively.
Prior to his current role, Greg served as an IT Manager at Janssen, where he was responsible for overseeing the implementation of critical IT infrastructures that supported the company’s pharmaceutical research and development efforts. This position allowed him to develop an in-depth understanding of both technology and regulatory compliance, thus ensuring that Janssen's digital strategies aligned with its overall business objectives.
Greg's extensive background in the industry began with his role as a Program Manager at J&J Pharmaceutical Research & Development, previously known as the Robert Wood Johnson Pharmaceutical Research Institute. In this role, he managed cross-functional teams, drove project timelines, and was instrumental in the successful development and deployment of various pharmaceutical products. His proactive approach and ability to foster collaboration across departments resulted in several successful product launches, contributing significantly to the company’s mission of developing innovative therapies.
Earlier in his career, Greg honed his consulting skills as a Principal Consultant at Pricewaterhouse Coopers, where he advised a range of clients on strategies to optimize their business processes. This experience not only provided him with insights into the operational challenges faced by healthcare organizations but also developed his expertise in navigating complex regulatory landscapes.
Education and Achievements
Greg Leibfreid holds a Bachelor of Business Administration in Economics from Temple University. His educational background has laid a strong foundation for his analytical skills and business acumen, which he has effectively applied throughout his career. Understanding economic principles has enabled Greg to approach challenges from a systemic viewpoint, considering both market forces and organizational dynamics in his decision-making processes.
His dedication to continuous learning and professional growth is evident from his career trajectory. Greg has actively participated in numerous professional development programs and industry conferences, ensuring that he remains at the forefront of technological advancements and industry trends. He recognizes the importance of staying informed in the rapidly changing landscape of medical informatics and pharmaceuticals, a commitment that sets him apart as a leader in his field.
Achievements
Throughout his career, Greg has achieved several notable milestones that reflect his leadership prowess and commitment to excellence in the pharmaceutical industry. As a Director at Janssen, he has played a crucial role in several high-impact projects that aim to improve patient care and streamline healthcare processes through innovative informatics solutions.
His ability to lead cross-functional teams has been recognized by senior management, and he has received several awards for his contributions to operational efficiencies and project delivery. Greg's work has not only advanced the goals of Janssen but has also contributed to broader industry standards in the utilization of medical informatics in enhancing healthcare delivery.
In summary, Greg Leibfreid is a respected leader in the field of medical informatics, with a proven track record of driving innovation and improving healthcare outcomes. His diverse experience across various organizations, coupled with his strong educational background, positions him as a significant contributor to the pharmaceutical landscape. His work continues to influence the integration of technology in healthcare, ultimately benefiting patients and the medical community alike.